Cyclosponne A (CsA)is an immunosuppressive drug that is widely used in transplantation medicine. Many of its suppressive effects appear to be related to inhibition of T lymphocyte function at the level of T cell receptor (TCR)-mediated activation events. Paradoxically, in certain situations CsA is responsible for the induction of a T cell-mediated autoimmunity. A potential explanation for this was obtained from our recent results which revealed two major effects of CsA on T cell development in the thymus: a) CsA inhibits the development of mature single positive (CD4+8- or CD4-8+) thymocytes without discernibly affecting the development of CD4-8- or CD4+8+ precursors or T cells expressing TCR-gamma delta, b) CsA interferes with the deletion of cells bearing autoreactive TCRs in the population of single positive thymocytes that do develop. The experiments proposed here seek to exploit these unexpected properties of CsA to gain new information on T cell development and autoimmunity. Specifically, the peripheral lymphoid tissues of CsA-treated mice will be tested for evidence of autoimmunity by examining in vitro T cell responses and by flow cytometric analysis of autoreactive TCR expression. The effects of CsA on positive selection, the process by which the developing T cell population is enriched for T cells capable of recognizing foreign antigens in association with self major histocompatibility complex (MHC)-encoded molecules, will also be tested. The cellular basis for CsA's effects will be explored with emphasis on the role of decreased intrathymic expression of MHC antigens, and on the involvement of suppressor cells and gamma delta-T cells. Successful completion of these experiments should increase our knowledge of the cellular mechanisms underlying autoimmunity. In addition, new information may be gained on the mode of action of CsA, an important, but poorly understood immunomodulatory drug.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI028365-01
Application #
3142839
Study Section
Immunological Sciences Study Section (IMS)
Project Start
1989-07-01
Project End
1992-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
1
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Urdahl, K B; Pardoll, D M; Jenkins, M K (1994) Cyclosporin A inhibits positive selection and delays negative selection in alpha beta TCR transgenic mice. J Immunol 152:2853-9
Kelner, G S; Minnerath, J M; Jenkins, M K et al. (1993) The murine immune response to the male-specific antigen mouse testicular cytochrome c. Eur J Immunol 23:1992-8
Kelner, G S; Jenkins, M K; Jemmerson, R (1993) A single amino acid substitution in a cytochrome c T cell stimulatory peptide changes the MHC restriction element from one isotype (I-Ak) to another (I-Ek). Mol Immunol 30:569-75
Urdahl, K B; Pardoll, D M; Jenkins, M K (1992) Self-reactive T cells are present in the peripheral lymphoid tissues of cyclosporin A-treated mice. Int Immunol 4:1341-9
Johnson, J G; Jenkins, M K (1992) Co-stimulatory functions of antigen-presenting cells. J Invest Dermatol 99:62S-65S
Norton, S D; Zuckerman, L; Urdahl, K B et al. (1992) The CD28 ligand, B7, enhances IL-2 production by providing a costimulatory signal to T cells. J Immunol 149:1556-61
Jenkins, M K (1992) The role of cell division in the induction of clonal anergy. Immunol Today 13:69-73
DeSilva, D R; Urdahl, K B; Jenkins, M K (1991) Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J Immunol 147:3261-7
Norton, S D; Hovinen, D E; Jenkins, M K (1991) IL-2 secretion and T cell clonal anergy are induced by distinct biochemical pathways. J Immunol 146:1125-9
Urdahl, K B; Jenkins, M K; Norton, S D (1991) Accessory cell-derived costimulatory signals regulate T cell proliferation. Ann N Y Acad Sci 636:33-42